Comparative Pharmacology
Head-to-head clinical analysis: PROTAMINE SULFATE versus PROTOPAM CHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROTAMINE SULFATE versus PROTOPAM CHLORIDE.
PROTAMINE SULFATE vs PROTOPAM CHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Protamine sulfate is a cationic protein that binds to heparin, an anionic anticoagulant, forming a stable complex that neutralizes heparin's anticoagulant activity. It also has mild anticoagulant properties of its own.
Reactivates acetylcholinesterase inhibited by organophosphate poisoning by binding to the organophosphate moiety, forming a complex that undergoes hydrolysis to regenerate active enzyme. Also has a direct neutralization effect on certain organophosphates.
1 mg IV per 100 units of heparin to be neutralized, administered slowly (not exceeding 5 mg/min) with continuous monitoring. Maximum single dose: 50 mg.
1-2 g IV over 15-30 minutes, may repeat after 1 hour if muscle weakness persists, then every 3-8 hours as needed for 24-48 hours.
None Documented
None Documented
Complex with heparin: 4–5 minutes (free protamine: 7.4 minutes). Clinically, the anticoagulant reversal effect is rapid but may be transient due to heparin rebound.
Terminal elimination half-life is approximately 1.7 hours in adults. In renal impairment, half-life may be prolonged up to 6 hours, requiring dose adjustment.
Primarily renal excretion (heparin-protamine complexes are cleared by the reticuloendothelial system; elimination is largely independent of renal function). <5% excreted unchanged in urine.
Renal excretion is the primary route, with 80-90% of a dose eliminated unchanged in urine within 30 minutes; the remainder is metabolized and excreted fecally.
Category A/B
Category C
Antidote
Antidote